Citation

Tschiffely AE, Haque A, Haran FJ, Cunningham CA, Mehalick ML, May T, Stuessi K, Walker PB, Norris JN. Mil. Med. 2018; 183(3-4): e140-e147.

Affiliation

Advanced Concepts & Applied Research Branch, SPAWAR Systems Center Pacific, San Diego, CA 92152.

Copyright

(Copyright © 2018, Association of Military Surgeons of the United States)

DOI

10.1093/milmed/usx036

PMID

29514349

Abstract

OBJECTIVE: The purpose of this study is to utilize a natural history approach to describe and understand symptom recovery in personnel diagnosed with a blast-related mild traumatic brain injury (mTBI) resulting from an improvised explosive device blast. PARTICIPANTS AND DESIGN: The population included military personnel who experienced a blast mTBI while mounted (vehicle; n = 176) or dismounted (on foot; n = 37) (N = 213). Patients had no co-morbid psychiatric or muscle-skeletal issues and were treated within 72 h of injury. Prevalence and duration of self-reported symptoms were separately analyzed by injury context (mounted vs dismounted).

RESULTS: Headache was prominently reported in both mounted (85%) and dismounted (75%) populations. The mean time from injury to return to full duty was between 7.8 d (mounted) and 8.5 d (dismounted). The dismounted population reported visual changes that lasted 0.74 d longer.

CONCLUSION: Our analysis implicates that headache is a common and acutely persistent symptom in mTBI regardless of injury context. Additionally, patients in mounted vs dismounted injury did not report significant differences in symptom prevalence. Although knowing the injury context (i.e., dismounted vs mounted) may be beneficial for providers to understand symptom presentations and deliver accurate anticipatory guidance for patients with blast-related mTBI, no significant differences were observed in this population. This may be due to the population characteristic as the trajectory of recovery may vary for patients who were not able to return to full duty within 30 d or required higher levels of care.

Language: en